Next Biomedical Co.,Ltd. (KOSDAQ:389650)
63,500
+1,600 (2.58%)
At close: Aug 28, 2025
Next Biomedical Revenue
Next Biomedical had revenue of 3.97B KRW in the quarter ending June 30, 2025, with 44.25% growth. This brings the company's revenue in the last twelve months to 12.16B, up 110.73% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.
Revenue (ttm)
12.16B
Revenue Growth
+110.73%
P/S Ratio
42.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
516.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.54B | 4.66B | 95.46% |
Dec 31, 2023 | 4.88B | 2.09B | 74.67% |
Dec 31, 2022 | 2.80B | 527.74M | 23.28% |
Dec 31, 2021 | 2.27B | 6.63M | 0.29% |
Dec 31, 2020 | 2.26B | 1.46B | 182.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hyundai Motor Company | 182.25T |
Hanwha Aerospace | 19.25T |
HD Hyundai Heavy Industries | 15.58T |
Doosan Enerbility | 16.30T |